Roles of mitochondrial transcription factor A and microRNA-590-3p in the development of colon cancer

Molecular Medicine Reports

Volumn 14, Issue 6, 2016, Pages 5475-5480

  Wu, Kaiming ^a   Zhao, Zhenxian ^b   Xiao, Yinglian ^a   Peng, Jianjun ^a   Chen, Jianhui ^a   He, Yulong ^a  

^a THE FIRST AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^b Pancreato Biliary Surgery   (China)

Author keywords

Colon cancer; MiRNA 590 3p; Mitochondrial transcription factor A; SW480 cells

Indexed keywords

MESSENGER RNA; MICRORNA; MICRORNA 590; MITOCHONDRIAL TRANSCRIPTION FACTOR A; UNCLASSIFIED DRUG; DNA BINDING PROTEIN; MIRN590 MICRORNA, HUMAN; MITOCHONDRIAL PROTEIN; TRANSCRIPTION FACTOR;

3' UNTRANSLATED REGION; ADULT; ARTICLE; CLINICAL ARTICLE; COLON CARCINOGENESIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; CELL CULTURE; CELL PROLIFERATION; COLON TUMOR; GENE EXPRESSION; GENETIC ASSOCIATION STUDY; GENETIC PREDISPOSITION; GENETICS; METABOLISM; RNA INTERFERENCE; TUMOR CELL LINE;

CELL LINE, TUMOR; CELL PROLIFERATION; CELLS, CULTURED; COLONIC NEOPLASMS; DNA-BINDING PROTEINS; GENE EXPRESSION; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MICRORNAS; MITOCHONDRIAL PROTEINS; RNA INTERFERENCE; RNA, MESSENGER; TRANSCRIPTION FACTORS;

EID: 84999287005     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2016.5955     Document Type: Article

References (31)

1. http://www.who.int/mediacentre/factsheets/fs297/en/. Accessed on 29 August 2012.
2. Bray F, Ren JS, Masuyer E and Ferlay J: Global estimates of cancer prevalence for 27 sites in the adult population in 2008. Int J Cancer 132: 1133-1145, 2013.
3. Bonawitz ND, Clayton DA and Shadel GS: Initiation and beyond: Multiple functions of the human mitochondrial transcription machinery. Mol Cell 24: 813-825, 2006.
4. Parisi MA and Clayton DA: Similarity of human mitochondrial transcription factor 1 to high mobility group proteins. Science 252: 965-969, 1991.
5. Litonin D, Sologub M, Shi Y, Savkina M, Anikin M, Falkenberg M, Gustafsson CM and Temiakov D: Human mitochondrial transcription revisited: Only TFAM and TFB2M are required for transcription of the mitochondrial genes in vitro. J Biol Chem 285: 18129-18133, 2010.
6. Tang D, Kang R, Zeh HJ III and Lotze MT: High-mobility group box 1 and cancer. Biochim Biophys Acta 1799: 131-140, 2010.
7. Baffy G: Uncoupling protein-2 and cancer. Mitochondrion 10: 243-252, 2010.
8. Yoshida Y, Hasegawa J, Nezu R, Kim YK, Hirota M, Kawano K, Izumi H and Kohno K: Clinical usefulness of mitochondrial transcription factor a expression as a predictive marker in colorectal cancer patients treated with FOLFOX. Cancer Sci 102: 578-582, 2011.
9. Toki N, Kagami S, Kurita T, Kawagoe T, Matsuura Y, Hachisuga T, Matsuyama A, Hashimoto H, Izumi H and Kohno K: Expression of mitochondrial transcription factor A in endometrial carcinomas: Clinicopathologic correlations and prognostic significance. Virchows Arch 456: 387-393, 2010.
10. Alam TI, Kanki T, Muta T, Ukaji K, Abe Y, Nakayama H, Takio K, Hamasaki N and Kang D: Human mitochondrial DNA is packaged with TFAM. Nucleic Acids Res 31: 1640-1645, 2003.
11. Kaufman BA, Durisic N, Mativetsky JM, Costantino S, Hancock MA, Grutter P and Shoubridge E: The mitochondrial transcription factor TFAM coordinates the assembly of multiple DNA molecules into nucleoid-like structures. Mol Biol Cell 18: 3225-3236, 2007.
12. Xu S, Zhong M, Zhang L, Wang Y, Zhou Z, Hao Y, Zhang W, Yang X, Wei A, Pei L and Yu Z: Overexpression of Tfam protects mitochondria against beta-amyloid-induced oxidative damage in SH-SY5Y cells. FEBS J 276: 3800-3809, 2009.
13. Aydin J, Andersson DC, Hänninen SL, Wredenberg A, Tavi P, Park CB, Larsson NG, Bruton JD and Westerblad H: Increased mitochondrial Ca2+ and decreased sarcoplasmic reticulum Ca2+ in mitochondrial myopathy. Hum Mol Genet 18: 278-288, 2009.
14. Kidani A, Izumi H, Yoshida Y, Kashiwagi E, Ohmori H, Tanaka T, Kuwano M and Kohno K: Thioredoxin2 enhances the damaged DNA binding activity of mtTFA through direct interaction. Int J Oncol 35: 1435-1440, 2009.
15. Bartel DP: MicroRNAs: Target recognition and regulatory functions. Cell 136: 215-233, 2009.
16. Petersen CP, Bordeleau ME, Pelletier J and Sharp PA: Short RNAs repress translation after initiation in mammalian cells. Mol Cell 21: 533-542, 2006.
17. Adam L, Zhong M, Choi W, Qi W, Nicoloso M, Arora A, Calin G, Wang H, Siefker-Radtke A, McConkey D, et al: MiR-200 expression regulates epithelial-to-mesenchymal transition in bladder cancer cells and reverses resistance to epidermal growth factor receptor therapy. Clin Cancer Res 15: 5060-5072, 2009.
18. Saito Y, Suzuki H, Tsugawa H, Nakagawa I, Matsuzaki J, Kanai Y and Hibi T: Chromatin remodeling at Alu repeats by epigenetic treatment activates silenced microRNA-512-5p with down regulation of Mcl-1 in human gastric cancer cells. Oncogene 28: 2738-2744, 2009.
19. Mazar J, DeYoung K, Khaitan D, Meister E, Almodovar A, Goydos J, Ray A and Perera RJ: The regulation of miRNA-211 expression and its role in melanoma cell invasiveness. PLoS One 5: e13779, 2010.
20. Di Leva G, Piovan C, Gasparini P, Ngankeu A, Taccioli C, Briskin D, Cheung DG, Bolon B, Anderlucci L, Alder H, et al: Estrogen mediated-activation of miR-191/425 cluster modulates tumorigenicity of breast cancer cells depending on estrogen receptor status. PLoS Genet 9: e1003311, 2013.
21. Rivas MA, Venturutti L, Huang YW, Schillaci R, Huang TH and Elizalde PV: Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development. Breast Cancer Res 14: R77, 2012.
22. Kalinowski FC, Giles KM, Candy PA, Ali A, Ganda C, Epis MR, Webster RJ and Leedman PJ: Regulation of epidermal growth factor receptor signaling and erlotinib sensitivity in head and neck cancer cells by miR-7. PLoS One 7: e47067, 2012.
23. Villa C, Fenoglio C, De Riz M, Clerici F, Marcone A, Benussi L, Ghidoni R, Gallone S, Cortini F, Serpente M, et al: Role of hnRNP-A1 and miR-590-3p in neuronal death: Genetics and expression analysis in patients with Alzheimer disease and frontotemporal lobar degeneration. Rejuvenation Res 14: 275-281, 2011.
24. Vinuesa CG, Rigby RJ and Yu D: Logic and extent of miRNA-mediated control of autoimmune gene expression. Int Rev Immunol 28: 112-138, 2009.
25. Benson AB III, Venook AP, Bekaii-Saab T, Chan E, Chen YJ, Cooper HS, Engstrom PF, Enzinger PC, Fenton MJ, Fuchs CS, et al; National Comprehensive Cancer Network: Colon cancer, version 3.2014. J Natl Compr Canc Netw 12: 1028-1059, 2014.
26. Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25: 402-408, 2001.
27. Belyavsky A, Vinogradova T and Rajewsky K: PCR-based cDNA library construction: General cDNA libraries at the level of a few cells. Nucleic Acids Res 17: 2919-2932, 1989.
28. Esquela-Kerscher A and Slack FJ: Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer 6: 259-269, 2006.
29. Bueno MJ and Malumbres M: MicroRNAs and the cell cycle. Biochim Biophys Acta 1812: 592-601, 2011.
30. Lieberman J, Slack F, Pandolfi PP, Chinnaiyan A, Agami R and Mendell JT: Noncoding RNAs and cancer. Cell 153: 9-10, 2013.
31. Kai-ming Wu, Yu-long He, Fa-keng Liu and Jian-hui Chen: Expression of mitochondrial transcription factor a in colon cancer and its role for proliferative regulation. Chinese Journal Of Bases And Clinics In General Surgery 22: 576-580, 2015.